Kane Biotech Announces Second Quarter 2026 Financial Results
WINNIPEG, Manitoba, Aug. 27, 2026 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announces today its second quarter 2026 financial results. Second Quarter 2026 Financial Highlights: Total revenue for the three months ended June 30, 2026 was $8,143 compared to $27,997 for the three months ended June 30, 2025. Revenue […]
Kane Biotech Inc. has unveiled its financial performance for the second quarter of 2026. This press release includes forward-looking statements that reflect the company's current beliefs, but may not reflect actual outcomes. The company cautioned that various risks and uncertainties could impact its results, including its financial condition, business development, intellectual property protection, and capital structure. For more details, refer to the company's disclosure documents available at www.sedarplus.ca.
Written by urgent.news from Financial Post's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
